[1]
|
Duley, L. (2009) The Global Impact of Pre-Eclampsia and Eclampsia. Seminars in Perinatology, 33, 130-137.
https://doi.org/10.1053/j.semperi.2009.02.010
|
[2]
|
Ghulmiyyah, L. and Sibai, B. (2012) Maternal Mortality from Preeclampsia/Eclampsia. Seminars in Perinatology, 36, 56-59. https://doi.org/10.1053/j.semperi.2011.09.011
|
[3]
|
邬瑞霞. 子痫前期对围产期结局的影响[J]. 现代诊断与治疗, 2007, 18(3): 188-189.
|
[4]
|
Ives, C.W., Sinkey, R., Rajapreyar, I., Tita, A.T.N. and Oparil, S. (2020) Preeclampsia—Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 76, 1690-1702.
https://doi.org/10.1016/j.jacc.2020.08.014
|
[5]
|
Palomaki, G.E., Haddow, J.E., Haddow, H.R., et al. (2015) Mod-eling Risk for Severe Adverse Outcomes Using Angiogenic Factor Measurements in Women with Suspected Preterm Preeclampsia. Prenatal Diagnosis, 35, 386-393.
https://doi.org/10.1002/pd.4554
|
[6]
|
Baltajian, K., Bajracharya, S., Salahuddin, S., et al. (2016) Sequential Plasma Angiogenic Factors Levels in Women with Suspected Preeclampsia. American Journal of Obstetrics and Gynecology, 215, 89.E1-89.E10.
https://doi.org/10.1016/j.ajog.2016.01.168
|
[7]
|
Ren, Y. (2018) Effect of SHH Signaling Pathway on Apoptosis and Invasion of Trophoblast Cells in Preeclampsia Patients and Its Mechanism. Journal of Jilin University (Medicine Edi-tion), 44, 510-515.
|
[8]
|
National Collaborating Centre for Women’s and Children’s Health (2010) Hypertension in Pregnancy: The Management of Hypertensive Disorders during Pregnancy. RCOG Press, London.
|
[9]
|
Abalos, E., Cuesta, C., Grosso, A.L., Chou, D. and Say, L. (2013) Global and Regional Estimates of Preeclampsia and Eclampsia: A Systematic Review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 170, 1-7.
https://doi.org/10.1016/j.ejogrb.2013.05.005
|
[10]
|
Shah, D.A. and Khalil, R.A. (2015) Bioactive Factors in Utero-placental and Systemic Circulation Link Placental Ischemia to Generalized Vascular Dysfunction in Hypertensive Preg-nancy and Preeclampsia. Biochemical Pharmacology, 95, 211-226. https://doi.org/10.1016/j.bcp.2015.04.012
|
[11]
|
Yu, W., Gao, W., Rong, D., Wu, Z.X. and Khalil, R.A. (2019) Mo-lecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia. Microcirculation, 26, e12508. https://doi.org/10.1111/micc.12508
|
[12]
|
English, F.A., Kenny, L.C. and Mccarthy, F.P. (2015) Risk Fac-tors and Effective Management of Preeclampsia. Integrated Blood Pressure Control, 8, 7-12. https://doi.org/10.2147/IBPC.S50641
|
[13]
|
Auger, N., Duplaix, M., Bilodeau-Bertrand, M., Lo, E. and Smargiassi, A. (2018) Environmental Noise Pollution and Risk of Preeclampsia. Environmental Pollution, 239, 599-606. https://doi.org/10.1016/j.envpol.2018.04.060
|
[14]
|
Cnossen, J.S., Vollebregt, K.C., De Vrieze, N., et al. (2008) Accuracy of Mean Arterial Pressure and Blood Pressure Measurements in Predicting Pre-Eclampsia: Systematic Review and Meta-Analysis. The BMJ, 336, 1117-1120.
https://doi.org/10.1136/bmj.39540.522049.BE
|
[15]
|
Miao, L. and Yang, L.X. (2018) Study on the Risk of Preeclampsia in Obese Pregnant Women with Serum Fibronectin. Journal of Clinical Transfusion and Laboratory Medi-cine, 20, 157-159.
|
[16]
|
Moutquin, J., Rainville, C., Giroux, L., et al. (1985) A Prospective Study of Blood Pressure in Pregnancy: Prediction of Preeclampsia. American Journal of Obstetrics and Gynecology, 151, 191-196.
https://doi.org/10.1016/0002-9378(85)90010-9
|
[17]
|
徐惠英, 郁君, 戴群. 孕 22~24周子宫动脉搏动指数在预测子痫前期中的价值[J]. 南京医科大学学报: 自然科学版, 2009(7): 1039-1041.
|
[18]
|
蒋荣珍, 钱智敏. 子痫前期的预测, 预防研究现状及进展[J]. 诊断学理论与实践, 2019, 18(6): 605-612.
|
[19]
|
Crispi, F., Domínguez, C., Llurba, E., et al. (2006) Placental Angiogenic Growth Factors and Uterine Artery Doppler Findings for Characterization of Dif-ferent Subsets in Preeclampsia and in Isolated Intrauterine Growth Restriction. American Journal of Obstetrics and Gy-necology, 195, 201-207. https://doi.org/10.1016/j.ajog.2006.01.014
|
[20]
|
Krishna, U. and Bhalerao, S. (2011) Pla-cental Insufficiency and Fetal Growth Restriction. The Journal of Obstetrics and Gynecology of India, 61, 505-511. https://doi.org/10.1007/s13224-011-0092-x
|
[21]
|
Vrachnis, N., Kalampokas, E., Sifakis, S., et al. (2013) Placental Growth Factor (PlGF): A Key to Optimizing Fetal Growth. The Journal of Maternal-Fetal & Neonatal Medicine, 26, 995-1002.
https://doi.org/10.3109/14767058.2013.766694
|
[22]
|
Gude, N.M., Roberts, C.T., Kalionis, B. and King, R.G. (2004) Growth and Function of the Normal Human Placenta. Thrombosis Research, 114, 397-407. https://doi.org/10.1016/j.thromres.2004.06.038
|
[23]
|
Zhou, Y., Mcmaster, M., Woo, K., et al. (2002) Vascular En-dothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Se-vere Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome. The American Journal of Pa-thology, 160, 1405-1423.
https://doi.org/10.1016/S0002-9440(10)62567-9
|
[24]
|
Zhou, Y., Genbacev, O. and Fisher, S.J. (2003) The Human Placenta Remodels the Uterus by Using a Combination of Molecules That Govern Vasculogenesis or Leukocyte Extrav-asation. Annals of the New York Academy of Sciences, 995, 73-83. https://doi.org/10.1111/j.1749-6632.2003.tb03211.x
|
[25]
|
周文哲, 曲洪美. 生物活性因子在妊娠期高血压疾病发病机制中的作用[J]. 国际妇产科学杂志, 2021, 48(4): 361-366.
|
[26]
|
Petla, L.T., Chikkala, R., Ratnakar, K., et al. (2013) Biomarkers for the Management of Pre-Eclampsia in Pregnant Women. Indian Journal of Medical Research, 138, 60-67.
|
[27]
|
Tan, K.H., Tan, S.S., Ng, M.J., et al. (2017) Extracellular Vesicles Yield Predictive Pre-Eclampsia Bi-omarkers. Journal of Extracellular Vesicles, 6, Article ID: 1408390. https://doi.org/10.1080/20013078.2017.1408390
|
[28]
|
Townsend, R., Khalil, A., Premakumar, Y., et al. (2019) Prediction of Pre-Eclampsia: Review of Reviews. Ultrasound in Obstetrics & Gynecology, 54, 16-27. https://doi.org/10.1002/uog.20117
|
[29]
|
Jackson, N., Biddolph, S., Ledger, W., Groome, N.P. and Manek, S. (2000) Inhibin Expression in Normal and Pre-Eclamptic Placental Tissue. International Journal of Gynecological Pathology, 19, 219-224.
https://doi.org/10.1097/00004347-200007000-00004
|
[30]
|
Katano, M., Okamoto, K., Arito, M., et al. (2009) Im-plication of Granulocyte-Macrophage Colony-Stimulating Factor Induced Neutrophil Gelatinase-Associated Lipocalin in Pathogenesis of Rheumatoid Arthritis Revealed by Proteome Analysis. Arthritis Research & Therapy, 11, Article No. R3. https://doi.org/10.1186/ar2587
|
[31]
|
Mishra, J., Ma, Q., Prada, A., et al. (2003) Identification of Neutrophil Gelati-nase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury. Journal of the American Soci-ety of Nephrology, 14, 2534-2543.
https://doi.org/10.1097/01.ASN.0000088027.54400.C6
|
[32]
|
Kim, S.M., Park, J.S., Norwitz, E.R., et al. (2013) Circulating Levels of Neutrophil Gelatinase—Associated Lipocalin (NGAL) Correlate with the Presence and Severity of Preeclampsi. Reproductive Sciences, 20, 1083-1089.
https://doi.org/10.1177/1933719113477480
|
[33]
|
Gerasimova, E.M., Fedotov, S.A., Kachkin, D.V., et al. (2019) Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics. International Journal of Molecular Sciences, 20, Article 6183.
https://doi.org/10.3390/ijms20246183
|
[34]
|
Watson, E.D., Geary-Joo, C., Hughes, M. and Cross, J.C. (2007) The Mrj Co-Chaperone Mediates Keratin Turnover and Prevents the Formation of Toxic Inclusion Bodies in Trophoblast Cells of the Placenta. Development, 134, 1809-1817. https://doi.org/10.1242/dev.02843
|